Omnix Medical Wins €10.8M in EIC Accelerator Funding
OmnixMedical, a Jerusalem-based biopharmaceutical company developing next-generation anti-infectives for the treatment of life-threatening infections, has been awarded €10.8 million in
Read moreOmnixMedical, a Jerusalem-based biopharmaceutical company developing next-generation anti-infectives for the treatment of life-threatening infections, has been awarded €10.8 million in
Read more